Differences in F36VMpl-based in vivo selection among large animal models

Molecular Therapy

Volumn 10, Issue 4, 2004, Pages 730-740

  Richard, Robert E ^a   De Claro, R Angelo ^a   Yan, James ^a   Chien, Sylvia ^a   von Recum, Horst ^a   Morris, Julia ^b   Kiem, Hans Peter ^b   Dalgarno, David C ^c   Heimfeld, Shelly ^b   Clackson, Tim ^c   Andrews, Robert ^b   Blau, C Anthony ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c ARIAD PHARMACEUTICALS INC   (United States)

Author keywords

Gene transfer; Hematopoietic stem cells; In vivo selection

Indexed keywords

AP 20187; CHEMICAL INDUCER OF DIMERIZATION; DRUG; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; MPL PROTEIN; RETROVIRUS VECTOR; THROMBOPOIETIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BABOON; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG RESPONSE; EX VIVO STUDY; FREQUENCY ANALYSIS; GENE THERAPY; GENETIC SELECTION; HEMATOPOIETIC CELL; IN VIVO STUDY; INTERNAL RIBOSOME ENTRY SITE; NONHUMAN; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; ANTIGENS, CD13; ANTIGENS, CD19; CELL DIFFERENTIATION; CELL LINE; DIMERIZATION; DOGS; GENE THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; INJECTIONS, INTRAVENOUS; MODELS, ANIMAL; ONCOGENE PROTEINS; PAPIO; RECEPTORS, CYTOKINE; RECEPTORS, THROMBOPOIETIN; RETROVIRIDAE; TACROLIMUS; TRANSDUCTION, GENETIC;

ANIMALIA; CANIS FAMILIARIS; MURINAE; PAPIO;

EID: 4644280255     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2004.07.005     Document Type: Article

References (41)

1. J.E. Dick et al. Introduction of a selectable gene into primitive stem cells capable of long-term reconstitution of the hemopoietic system of W/Wv mice Cell 42 1985 71-79
2. D.A. Williams et al. Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse Nature 310 1984 476-480
3. C. May et al. Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin Nature 406 2000 82-86
4. R. Pawliuk et al. Correction of sickle cell disease in transgenic mouse models by gene therapy Science 294 2001 2368-2371
5. C. Baum et al. Side effects of retroviral gene transfer into hematopoietic stem cells Blood 101 2003 2099-2144
6. Z. Li et al. Murine leukemia induced by retroviral gene marking Science 296 2002 497
7. J.L. Abkowitz et al. Behavior of hematopoietic stem cells in a large animal Proc. Natl. Acad. Sci. USA 92 1995 2031-2035
8. J.L. Abkowitz et al. Evidence that the number of hematopoietic stem cells per animal is conserved in mammals Blood 100 2002 2665-2667
9. J.F. Tisdale et al. Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability Blood 92 1998 1131-1141
10. C.E. Dunbar et al. Improved retroviral gene transfer into murine and rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor Proc. Natl. Acad. Sci. USA 93 1996 11871-11876
11. H.P. Kiem et al. Gene transfer into marrow repopulating cells: comparison between amphotropic and gibbon ape leukemia virus pseudotyped retroviral vectors in a competitive repopulation assay in baboons Blood 90 1997 4638-4645
12. H.P. Kiem et al. Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor Blood 92 1998 1878-1886
13. E.D. Zanjani G. Almeida-Porada A.W. Flake Retention and multilineage expression of human hematopoietic stem cells in human-sheep chimeras Stem Cells 13 1995 101-111
14. J.E. Dick Human stem cell assays in immune-deficient mice Curr. Opin. Hematol. 3 1996 405-409
15. J.E. Dick et al. Assay of human stem cells by repopulation of NOD/SCID mice Stem Cells 15 Suppl. 1 1997 199-203 discussion 204-207
16. J.A. Allay et al. In vivo selection of retrovirally transduced hematopoietic stem cells Nat. Med. 4 1998 1136-1143
17. N. Sawai et al. Reduction in hematopoietic stem cell numbers with in vivo drug selection can be partially abrogated by HOXB4 gene expression Mol. Ther. 8 2003 376-384
18. C.R. Ozawa M.L. Springer H.M. Blau A novel means of drug delivery: myoblast-mediated gene therapy and regulatable retroviral vectors Annu. Rev. Pharmacol. Toxicol. 40 2000 295-317
19. S. Kirby W. Walton O. Smithies Hematopoietic stem cells with controllable tEpoR transgenes have a competitive advantage in bone marrow transplantation Blood 95 2000 3710-3715
20. B.P. Sorrentino Gene therapy to protect haematopoietic cells from cytotoxic cancer drugs Nat. Rev. Cancer 2 2002 431-441
21. T. Neff C.A. Blau Pharmacologically regulated cell therapy Blood 97 2001 2535-2540
22. C.A. Blau T. Neff T. Papayannopoulou The hematological effects of folate analogs: implications for using the dihydrofolate reductase gene for in vivo selection Hum. Gene Ther. 7 1996 2069-2078
23. J.A. Allay et al. Sensitization of hematopoietic stem and progenitor cells to trimetrexate using nucleoside transport inhibitors Blood 90 1997 3546-3554
24. D.A. Persons et al. Transient in vivo selection of transduced peripheral blood cells using antifolate drug selection in rhesus macaques transplanted with hematopoietic stem cells expressing dihydrofolate reductase vectors Blood 14 2003 14
25. L. Jin et al. In vivo selection using a cell-growth switch Nat. Genet. 26 2000 64-66
26. T. Neff et al. Pharmacologically regulated in vivo selection in a large animal Blood 100 2002 2026-2031
27. R.E. Richard et al. Expansion of genetically modified primary human hemopoietic cells using chemical inducers of dimerization Blood 95 2000 430-436
28. R.E. Richard C.A. Blau Small-molecule-directed mpl signaling can complement growth factors to selectively expand genetically modified cord blood cells Stem Cells 21 2003 71-78
29. R.G. Hawley et al. Versatile retroviral vectors for potential use in gene therapy Gene Ther. 1 1994 136-138
30. I.R. Ghattas J.R. Sanes J.E. Majors The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos Mol. Cell. Biol. 11 1991 5848-5859
31. T. Clackson et al. Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity Proc. Natl. Acad. Sci. USA 95 1998 10437-10442
32. J.D. Iuliucci et al. Intravenous safety and pharmacokinetics of a novel dimerizer drug, AP1903, in healthy volunteers J. Clin. Pharmacol. 41 2001 870-879
33. P.A. Horn et al. Highly efficient gene transfer into baboon marrow repopulating cells using GALV-pseudotype oncoretroviral vectors produced by human packaging cells Blood 100 2002 3960-3967 Published online August 8, 2002
34. Z. Li et al. Predictable and efficient retroviral gene transfer into murine bone marrow repopulating cells using a defined vector dose Exp. Hematol. 31 2003 1206-1214
35. P.A. Horn et al. Distinct hematopoietic stem/progenitor cell populations are responsible for repopulating NOD/SCID mice compared with nonhuman primates Blood 102 2003 4329-4335 Published online June 19, 2003
36. R.G. Hawley et al. Thrombopoietic potential and serial repopulating ability of murine hematopoietic stem cells constitutively expressing interleukin 11 Proc. Natl. Acad. Sci. USA 93 1996 10297-10302
37. L. Cheng et al. Sustained gene expression in retrovirally transduced, engrafting human hematopoietic stem cells and their lympho-myeloid progeny Blood 92 1998 83-92
38. L. Jin et al. Targeted expansion of genetically modified bone marrow cells Proc. Natl. Acad. Sci. USA 95 1998 8093-8097
39. R.E. Richard et al. Modulating erythrocyte chimerism in a mouse model of pyruvate kinase deficiency Blood 26 2004 26
40. T. Neff et al. Methylguanine methyltransferase-mediated in vivo selection and chemoprotection of allogeneic stem cells in a large-animal model J. Clin. Invest. 112 2003 1581-1588
41. C.A. Blau et al. A proliferation switch for genetically modified cells Proc. Natl. Acad. Sci. USA 94 1997 3076-3081